Reducing hospital inpatient length of stay for patients with diabetes

Cavan, D. A.; Hamilton, Paul; Everett, Joan; Kerr, David

doi:10.1046/j.1464-5491.2001.00420.x

Cited by 54 publications

(47 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Their involvement shortens patient stay and improves safety [22][23][24][25]. The Diabetes Specialist Team should be informed as soon as possible during the acute phase, but this will depend on local circumstances.…”

Section: The Involvement Of Diabetes Specialist Teamsmentioning

confidence: 99%

Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis

Savage

Dhatariya²,

Kilvert³

et al. 2011

Diabetic Medicine

291

297

View full text Add to dashboard Cite

The Joint British Diabetes Societies guidelines for the management of diabetic ketoacidosis (these do not cover Hyperosmolar Hyperglycaemic Syndrome) are available in full at: This article summarizes the main changes from previous guidelines and discusses the rationale for the new recommendations. The key points are: Monitoring of the response to treatment (i) The method of choice for monitoring the response to treatment is bedside measurement of capillary blood ketones using a ketone meter.(ii) If blood ketone measurement is not available, venous pH and bicarbonate should be used in conjunction with bedside blood glucose monitoring to assess treatment response.(iii) Venous blood should be used rather than arterial (unless respiratory problems dictate otherwise) in blood gas analysers.(iv) Intermittent laboratory confirmation of pH, bicarbonate and electrolytes only.Insulin administration (i) Insulin should be infused intravenously at a weight-based fixed rate until the ketosis has resolved.(ii) When the blood glucose falls below 14 mmol ⁄ l, 10% glucose should be added to allow the fixed-rate insulin to be continued.(iii) If already taking, long-acting insulin analogues such as insulin glargine (Lantus Ò

show abstract

Section: The Involvement Of Diabetes Specialist Teamsmentioning

confidence: 99%

Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis

Savage

Dhatariya²,

Kilvert³

et al. 2011

Diabetic Medicine

291

297

View full text Add to dashboard Cite

show abstract

“…Westert and colleagues show that the variation in LOS is larger between hospitals than within them [10]. Cavan and colleagues showed that length of stay in hospitals for patients with diabetes was significantly reduced when a ward-based diabetes nurse adviser was introduced [11]. This indicates that variables other than the case-mix can explain LOS variation.…”

Section: Length Of Stay In Hospitalmentioning

confidence: 99%

Primary health care and hospital interactions: Effects for hospital length of stay

Kjekshus

2005

Scand J Public Health

View full text Add to dashboard Cite

show abstract

“…Various authors have attempted to determine the factors that predict or modify the length of hospitalization in patients with pathologies prevalent in our setting, such as chronic obstructive pulmonary disease [1] , heart failure [2] , diabetes mellitus [3] , acute myocardial infarction [4] and pneumonia.…”

Section: Introductionmentioning

confidence: 99%

Factors Influencing Length of Hospital Stay in Patients with Bacterial Pleural Effusion

Soriano¹,

Alegre²,

Alemán³

et al. 2005

Respiration

View full text Add to dashboard Cite

Background: Factors influencing length of hospital stay have been poorly analyzed in parapneumonic pleural effusions (PPE). Objectives: The aim of this work is to identify the variables that determine increased hospital stay in patients with infectious pleural effusion (PE). Patients and Methods: We analyzed 112 patients with PE: empyema, complicated parapneumonic and non-complicated parapneumonic. Epidemiologic, biochemical, therapeutic and radiological variables were analyzed. Correlations with hospital stay were studied using the Student’s t test, analysis of variance, Mann-Whitney U-test and linear regression model. Results: Among the 112 patients studied, there were 32 empyema, 50 complicated and 30 non-complicated parapneumonic cases. The median of length stay for all patients was 17 days. Longer hospitalization was required in patients with empyemic PE (p = 0.015), patients with underlying diseases (p = 0.003), those needing pleural drainage (p = 0.005) or decortication (p = 0.043) and those presenting unfavorable radiological outcome after treatment (p = 0.02). Biochemical parameters associated with longer hospital stay were elevated pleural fluid polymorphonuclear elastase (p = 0.001, r = 0.307) and lactate dehydrogenase (p = 0.001, r = 0.312). After linear regression analysis, only underlying disease, pleural drainage and pleural fluid polymorphonuclear elastase values remained in the model, explaining 23.1% of the variability of days of hospitalization. Conclusions: The patients with PPE and empyema who required longer hospitalization were those with purulent fluid, underlying disease, surgical drainage and/or decortication, with unfavorable radiological outcome and higher pleural fluid levels of lactate dehydrogenase and polymorphonuclear elastase.

show abstract

Reducing hospital inpatient length of stay for patients with diabetes

Cited by 54 publications

References 0 publications

Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis

Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis

Primary health care and hospital interactions: Effects for hospital length of stay

Factors Influencing Length of Hospital Stay in Patients with Bacterial Pleural Effusion

Contact Info

Product

Resources

About